E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9

Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, 24, 908, 10.1038/s41591-018-0104-9 Zhou, 2020, Epidemiological features of NAFLD from 1999 to 2018 in China, Hepatology, 71, 1851, 10.1002/hep.31150 Estes, 2018, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, 67, 123, 10.1002/hep.29466 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Chang, 2015, Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1, Hepatology, 62, 1070, 10.1002/hep.27921 Hwang, 2020, Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets, Hepatology, 72, 412, 10.1002/hep.31031 He, 2019, MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes, Hepatology, 70, 1150, 10.1002/hep.30645 Tran, 2013, Non-alcoholic steatohepatitis in morbidly obese patients, Clin Res Hepatol Gastroenterol, 37, 17, 10.1016/j.clinre.2012.07.005 Du Plessis, 2015, Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease, Gastroenterology, 149, 635, 10.1053/j.gastro.2015.05.044 Ley, 2007, Getting to the site of inflammation: the leukocyte adhesion cascade updated, Nat Rev Immunol, 7, 678, 10.1038/nri2156 Vestweber, 1999, Mechanisms that regulate the function of the selectins and their ligands, Physiol Rev, 79, 181, 10.1152/physrev.1999.79.1.181 Luscinskas, 1996, Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment, Ann Rev Med, 47, 413, 10.1146/annurev.med.47.1.413 Katayama, 2005, CD44 is a physiological E-selectin ligand on neutrophils, J Exp Med, 201, 1183, 10.1084/jem.20042014 Bertola, 2013, Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin, Hepatology, 58, 1814, 10.1002/hep.26419 Wang, 2018, S100A8/A9 in inflammation, Front Immunol, 9, 1298, 10.3389/fimmu.2018.01298 Kraakman, 2017, Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes, J Clin Invest, 127, 2133, 10.1172/JCI92450 Pruenster, 2016, S100A8/A9: from basic science to clinical application, Pharmacol Ther, 167, 120, 10.1016/j.pharmthera.2016.07.015 Ryckman, 2003, Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion, J Immunol, 170, 3233, 10.4049/jimmunol.170.6.3233 Nacken, 2003, S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity, Microsc Res Tech, 60, 569, 10.1002/jemt.10299 Schiopu, 2013, S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease, Mediat Inflamm, 2013, 10.1155/2013/828354 Catalán, 2011, Increased levels of calprotectin in obesity are related to macrophage content: Impact on inflammation and effect of weight loss, Mol Med, 17, 1157, 10.2119/molmed.2011.00144 Serhal, 2015, Nonalcoholic steatohepatitis: Involvement of the telomerase and proinflammatory mediators, Biomed Res Int, 2015, 10.1155/2015/850246 Björk, 2009, Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides, PLoS Biol, 7, e97, 10.1371/journal.pbio.1000097 McDonald, 2008, Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids, J Exp Med, 205, 915, 10.1084/jem.20071765 Lake, 2011, Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease, Drug Metab Dispos, 39, 1954, 10.1124/dmd.111.040592 Feldstein, 2003, Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis, Gastroenterology, 125, 437, 10.1016/S0016-5085(03)00907-7 Ait Ahmed, 2021, Kupffer cell restoration after partial hepatectomy is mainly driven by local cell proliferation in IL-6-dependent autocrine and paracrine manners, Cell Mol Immunol, 10.1038/s41423-021-00731-7 Guillot, 2021, Bile acid–activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury, J Clin Invest, 131, 10.1172/JCI132305 Rada, 2020, Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?, Cell Death Dis, 11, 1, 10.1038/s41419-020-03003-w Bijnen, 2018, Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice, Gut, 67, 1317, 10.1136/gutjnl-2016-313654 Kim, 2019, Adipocyte death preferentially induces liver injury and inflammation through the activation of chemokine (C-C motif) receptor 2-positive macrophages and lipolysis, Hepatology, 69, 1965, 10.1002/hep.30525 Frühbeck, 2014, Regulation of adipocyte lipolysis, Nutr Res Rev, 27, 63, 10.1017/S095442241400002X Polyzos, 2009, Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines, Curr Mol Med, 9, 299, 10.2174/156652409787847191 Kucukoglu, 2021, Hepatokines and adipokines in NASH-related hepatocellular carcinoma, J Hepatol, 74, 442, 10.1016/j.jhep.2020.10.030 Rodríguez, 2013, Metabolism and satiety, 75 Singh, 2015, Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies, Clin Gastroenterol Hepatol, 13, 643, 10.1016/j.cgh.2014.04.014 Schuster, 2018, Triggering and resolution of inflammation in NASH, Nat Rev Gastroenterol Hepatol, 15, 349, 10.1038/s41575-018-0009-6 Hwang, 2020, Protective and detrimental roles of p38α mitogen-activated protein kinase in different stages of nonalcoholic fatty liver disease, Hepatology, 72, 873, 10.1002/hep.31390 Simons, 2020, The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease, Liver Int, 40, 1079, 10.1111/liv.14384 Flach, 2013, β3-adrenergic receptor stimulation induces e-selectin-mediated adipose tissue inflammation, J Biol Chem, 288, 2882, 10.1074/jbc.M112.412346 Musso, 2008, Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects, Diabetes Care, 31, 562, 10.2337/dc07-1526 Velázquez, 2019, Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice, World J Hepatol, 11, 619, 10.4254/wjh.v11.i8.619 Ivetic, 2019, L-selectin: a major regulator of leukocyte adhesion, migration and signaling, Front Immunol, 10, 1068, 10.3389/fimmu.2019.01068 Liu, 2017, L-selectin mechanochemistry restricts neutrophil priming in vivo, Nat Commun, 8, 1 Drescher, 2020, L-selectin/CD62L is a key driver of non-alcoholic steatohepatitis in mice and men, Cells, 9, 1106, 10.3390/cells9051106 Yilmaz, 2009, Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance, Eur J Gastroenterol Hepatol, 21, 1247, 10.1097/MEG.0b013e32832b77ae Martínez-Castillo, 2020, Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression, Mol Cell Biochem, 469, 65, 10.1007/s11010-020-03728-4 Hagström, 2017, IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD–a pilot study, Scand J Gastroenterol, 52, 1427, 10.1080/00365521.2017.1379556 Hessian, 1993, MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes, J Leukoc Biol, 53, 197, 10.1002/jlb.53.2.197 Zhang, 2014, Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study, Sci Rep, 4, 1 Malhi, 2008, Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease, Semin Liver Dis, 28, 360, 10.1055/s-0028-1091980 Alkhouri, 2009, Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal, Exp Rev Gastroenterol Hepatol, 3, 445, 10.1586/egh.09.32 Huebert, 2010, Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis, Lab Invest, 90, 1770, 10.1038/labinvest.2010.132